![Gerald McMahon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerald McMahon
No open positions remaining
Profile
Gerald McMahon served as President at Sugen, Inc. from 1993 to 2004.
From 2004 to 2012, held the position of Non-Executive Chairman at Poniard Pharmaceuticals, Inc. Between 2010 and 2012, was Senior VP-Oncology Innovative Medicines Unit at MedImmune LLC.
From 2011 to 2016, worked as Independent Director at Oncotelic Therapeutics, Inc. Served as Director at Celldex Therapeutics, Inc. from 2016 to 2018.
Held roles of President, Chief Executive Officer & Director at Kolltan Pharmaceuticals, Inc., Harpoon Therapeutics, Inc. from 2016 to 2021, and STORM Therapeutics Ltd. Also held positions as Director at Trellis Bioscience, Inc., Senior Vice President-Research & Development at Pharmacia Corp., Staff Investigator at Massachusetts Institute of Technology, and Venture Partner at Bay City Capital LLC.
Education includes undergraduate and doctorate degrees from Rensselaer Polytechnic Institute, with the doctorate conferred in 1980.
Former positions of Gerald McMahon
| Companies | Position | End |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Chief Executive Officer | 26/10/2021 |
| CELLDEX THERAPEUTICS, INC. | Director/Board Member | 05/12/2018 |
| ONCOTELIC THERAPEUTICS, INC. | Director/Board Member | 23/11/2016 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01/05/2012 |
| PONIARD PHARMACEUTICALS, INC. | Chief Executive Officer | 05/02/2010 |
Training of Gerald McMahon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Poniard Pharmaceuticals, Inc.
 Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Trellis Bioscience, Inc.
 Trellis Bioscience, Inc. BiotechnologyHealth Technology Develops treatments for infectious diseases, cancer and oncology indications | Health Technology |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures monoclonal antibody drugs | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecule drugs through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases | Health Technology |
- Stock Market
- Insiders
- Gerald McMahon
